David Colquhoun in his office at UCL: ‘People simply still don’t get that to prove “effect B” is caused by “intervention A” you have to use randomised controlled testing.’ Photograph: Karen Robinson
Professor of pharmacology David Colquhoun is the take-no-prisoners debunker of pseudoscience on his unmissable blog
David Colquhoun, professor of pharmacology at University College London for 30 years, has lately led a double life. In his day job, he has pioneered painstaking research into the binding properties of molecules and contributed extensively to understanding the particular influences on ion channel function in the development of drugs. In his after-hours alter ego, however, he is the take-no-prisoners scourge of quackery and mumbo-jumbo in his unmissable blog, DC’s Improbable Science.
A year has passed since President Barack Obama enacted a law intended to spark business growth by encouraging “crowdfunding” of startups. Much of the law remains to be implemented, but that hasn’t stopped crowdfunding sites Poliwogg and Microryza from employing different models toward raising money for biopharmas and researchers, respectively.
This month, Poliwogg is launching its platform, focusing on helping fund small- and mid-sized companies in biopharma and other “healthcare” specialties, as well as in community-based businesses and projects, and portfolios of high-yielding investment-grade assets…